Skip to content

EBIT at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Idexx Laboratories logo
Idexx LaboratoriesIDXX
Zoetis logo
ZoetisZTS
Revvity logo
RevvityRVTY
TEC
Bio-TechneTECH
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$1.92B+12.0%
Enterprise value$2.56B+4.4%
P/S2.2×+0.3×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Calculated from Neogen’s reported figures.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's EBIT?
Neogen (NEOG) reported EBIT of -$3.3M in Q4 2025.
How has Neogen's EBIT changed year-over-year?
Neogen's EBIT decreased by 161.1% year-over-year, from $5.4M to -$3.3M.
What is the long-term trend for Neogen's EBIT?
Over 4 years (2021 to 2025), Neogen's EBIT has grown at a 94.5% compound annual growth rate (CAGR), from $74.17M to -$1.06B.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.